M. Wang

Targeting Bruton's tyrosine kinase with ibrutinib in B‐cell malignancies

R. Champlin, R. Champlin, Y. Wang, 2015, Clinical pharmacology and therapeutics.

Oral Abstract: MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study

A. Alencar, I. Flinn, P. Zinzani, 2022, Clinical Lymphoma Myeloma and Leukemia.

Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.

H. Miao, Z. Pan, X. He, 2021, Clinical radiology.

Comparison of angio-CT versus multidetector CT in the detection and location for insulinomas.

K. Yuan, M. Wang, J. Fu, 2020, Clinical radiology.

The safety and efficacy of transarterial chemoembolisation with bleomycin for hepatocellular carcinoma unresponsive to doxorubicin: a prospective single-centre study.

K. Yuan, Y. Guan, M. Wang, 2021, Clinical radiology.